Grants / Department of Health and Human Services / Centers for Disease Control - NCHHSTP

CDC-RFA-PS22-2208: Strengthening Syringe Services Programs

Closed Closed May 2, 2022 Opportunity CDC-RFA-PS22-2208 ☆ Save

This grant is closed. A newer notice from the same program is forecast: Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use (CDC-RFA-PS-27-0239). Status: Expected deadline May 24, 2027. It is in our archive of Centers for Disease Control - NCHHSTP notices from 2022.

• Total funding$50.0 million
• Expected awards2
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to any type of organization.

Applicants are invited to apply to one or two components, if desired. Applicants are permitted to submit only one application. If you are applying for both components, one application should be submitted with two separate narratives, workplans, and budgets required. CDC will not consider multiple applications from a single applicant. The application will be considered as nonresponsive and will receive no further review if the requirements in this section are not met.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (87% over five years) went to nonprofits.
• No cost sharing or match is required.

What the grant funds

This NOFO aims to increase access to harm reduction services for people who currently inject or have a history of injecting drugs (PWID) and reduce incidence of infectious diseases and complications of injection drug use through two components. Component 1 will expand a national network of syringe services programs (SSPs) to facilitate communication and networking among SSPs, other harm reduction programs, and trusted national organizations with a demonstrated portfolio in improving the health of persons who use drugs (PWUD). This component also improves data about SSPs by surveying SSPs to document capacity, needs, and service gaps. Component 2 will increase support and resources to SSPs for implementation of distribution of sterile injection supplies and disposal of used injection supplies; testing, treatment, and prevention of infectious diseases and infectious complications from injection drug use; and mitigation of other harms due to drug use. Applicants may apply for Component 1, Component 2, or both. Expected outcomes include: improved collaboration, communication, and data about SSPs nationwide; increased access to harm reduction services; decreased unsafe injection practices; decreased new infections of HCV, HBV, HAV, HIV, endocarditis, and other infections; decreased overdose rates and mortality; increased capacity for responding to outbreaks of infections associated with injection drug use; and increased services available through SSPs in the United States.

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, CDC-RFA-PS-27-0239, which is forecast.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.